Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit.
Standard
Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit. / Augustin, Matthias; Schäfer, Ines; Rabini, S; Lee-Seifert, Christine Julie; Radtke, Marc; Rustenbach, Stephan Jeff.
In: DERMATOLOGY, Vol. 218, No. 3, 3, 2009, p. 255-259.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit.
AU - Augustin, Matthias
AU - Schäfer, Ines
AU - Rabini, S
AU - Lee-Seifert, Christine Julie
AU - Radtke, Marc
AU - Rustenbach, Stephan Jeff
PY - 2009
Y1 - 2009
N2 - BACKGROUND: Supportive skin care for irritated and inflamed skin is one of the most important measures in the prevention and treatment of eczema and sensitive skin. OBJECTIVES: To develop and validate an instrument for the evaluation of patient-relevant benefit in the supportive care of irritated skin with nonpharmacological topical agents. METHODS: Patient-defined treatment objectives and benefits of supportive skin care were determined in an open survey of patients with irritated skin. A pilot questionnaire was constructed according to the Patient Benefit Index (PBI). The questionnaire was tested for feasibility and validity in 1,886 patients with various irritated skin conditions. RESULTS: From a total of 90 characteristics of basic therapy benefit, a 23-item questionnaire was constructed. This questionnaire ('PBI-k') proved to be feasible, reliable and was associated with a high level of patient acceptance in the surveillance field. The questionnaire showed good internal consistency, distribution characteristics and convergent validity with patient satisfaction. CONCLUSION: The PBI-k is the first specific instrument developed for the evaluation of patient-defined benefit in supportive skin care with nonpharmacological topical agents. Feasibility and psychometric properties make this questionnaire suitable for application in studies involving patients with irritated, sensitive skin.
AB - BACKGROUND: Supportive skin care for irritated and inflamed skin is one of the most important measures in the prevention and treatment of eczema and sensitive skin. OBJECTIVES: To develop and validate an instrument for the evaluation of patient-relevant benefit in the supportive care of irritated skin with nonpharmacological topical agents. METHODS: Patient-defined treatment objectives and benefits of supportive skin care were determined in an open survey of patients with irritated skin. A pilot questionnaire was constructed according to the Patient Benefit Index (PBI). The questionnaire was tested for feasibility and validity in 1,886 patients with various irritated skin conditions. RESULTS: From a total of 90 characteristics of basic therapy benefit, a 23-item questionnaire was constructed. This questionnaire ('PBI-k') proved to be feasible, reliable and was associated with a high level of patient acceptance in the surveillance field. The questionnaire showed good internal consistency, distribution characteristics and convergent validity with patient satisfaction. CONCLUSION: The PBI-k is the first specific instrument developed for the evaluation of patient-defined benefit in supportive skin care with nonpharmacological topical agents. Feasibility and psychometric properties make this questionnaire suitable for application in studies involving patients with irritated, sensitive skin.
M3 - SCORING: Zeitschriftenaufsatz
VL - 218
SP - 255
EP - 259
JO - DERMATOLOGY
JF - DERMATOLOGY
SN - 1018-8665
IS - 3
M1 - 3
ER -
